Pharmacy waited for years, why make changes so quickly after Bawa-Garba?
Professor Sir Norman Williams has just sent the secretary of state for health and social care, Jeremy Hunt, his review of gross negligence manslaughter in healthcare, and the review makes a number of points that are important to all healthcare professionals.
His covering letter to Mr Hunt stresses the “profound effect” that a patient death, caused by a medical error, has on healthcare professionals.
Professor Williams also notes that the effect of healthcare professionals can be “compounded by an investigation which may seek to blame, rather than to understand the factors that have led to the tragedy, so that lessons can be learned to prevent future incidents”.
“At all stages of any investigation the stress levels for those involved, including the professionals, can be overwhelming,” he adds. “For healthcare professionals, a sense of fear pervades and patient safety is jeopardised as they become cautious about being open and transparent, impeding the opportunity for lessons to be learned.”
The review makes the following points:
- Evidence suggested that a disproportionate number of black, Asian and minority ethnic professionals are involved in criminal and regulatory investigations. Professor Williams recommended looking into this, and suggested that fitness-to-practise panel members should receive equality and diversity training.
- Although a key function of regulators like the General Pharmaceutical Council is to maintain public confidence in the profession, there is little understanding about the type of behaviours and failings that might lead to the public losing confidence in the profession and which therefore constitute grounds for regulatory action. The review panel called for a review on how public confidence is assessed, and for guidance to support consistent decision making.
- There was concern that healthcare professionals who did not have legal representation in fitness-to-practise proceedings were more likely to be struck off – a point I also made in my recent blog.
- The panel recommended that the Professional Standards Authority should look into the inconsistency of decisions by different healthcare regulators in relation to similar incidents.
Much of what the review says about manslaughter prosecutions is equally applicable to prosecutions for dispensing errors under section 64 of the Medicines Act 1968. This leaves me wondering why it took 10 years for pharmacists to get partial decriminalisation, but just four months after an outcry from the medical profession over Dr Bawa-Garba’s case, the secretary of state has accepted Professor Williams’ recommendations.
This article was written by David Reissner and published by Chemist+Druggist on 19 June 2018. For more information, please contact David on +44 (0)20 7203 5065 or at firstname.lastname@example.org.
News & Insights
The menopause - can business afford to ignore the potential productivity loss of 14 million days a year?
It is clearly in the interests of business to retain the talent and experience of those working women who are dealing with the menopause.
Charles Russell Speechlys advises Kreos on growth capital investment in JenaValve Technologies, Inc.
Charles Russell Speechlys advised Kreos on its growth capital investment in a biotech company, JenaValve Technologies, Inc.
Charles Russell Speechlys advises Juno Health pharmacy group on its acquisition of the Avicenna Pharmacy group
Juno Health further establishes its position as one of the largest pharmacy chains in the Northeast of England.